West African Emerging Infectious Disease Research Center (WA-EIDRC)

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3U01AI151812-04S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2025
  • Known Financial Commitments (USD)

    $801,785
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    ASSOCIATE PROFESSOR Kristian Andersen
  • Research Location

    United States of America
  • Lead Research Institution

    SCRIPPS RESEARCH INSTITUTE, THE
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Prior studies have shown that prior to the pandemic, Sierra Leoneans had more frequent exposures than Americans to coronaviruses with epitopes that cross-react with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), SARS-CoV, and Middle Eastern respiratory syndrome coronavirus (MERS-CoV). Prior exposure to coronaviruses that induce cross-protective immunity may contribute to the greatly reduced incidence of COVID-19 cases and deaths in Sierra Leone compared to the United States. This supplement will (1) define the humoral immune response of Sierra Leoneans that may protect against infection with SARS-CoV-2 through isolation and characterization of pre-pandemic monoclonal antibodies, (2) develop diagnostic tests for novel coronaviruses and (3) determine the protective responses of cross neutralizing monoclonal antibodies in a nonhuman primate COVID-19 model.